Clinical Trial Update: STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS [Phase 2]

View source ↗

Summary

Phase 2 trial comparing three ixazomib-based regimens (ixazomib with dexamethasone; ixazomib with cyclophosphamide and dexamethasone; ixazomib with thalidomide …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Thalidomide (thalidomide)
• ixazomib (ixazomib)

Snippet

Sponsor: Mario Boccadoro | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED